227 related articles for article (PubMed ID: 22325036)
1. Distinct overlapping sequences at the carboxy-terminus of merlin regulate its tumour suppressor and morphogenic activity.
Laulajainen M; Melikova M; Muranen T; Carpén O; Grönholm M
J Cell Mol Med; 2012 Sep; 16(9):2161-75. PubMed ID: 22325036
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton.
Laulajainen M; Muranen T; Carpén O; Grönholm M
Oncogene; 2008 May; 27(23):3233-43. PubMed ID: 18071304
[TBL] [Abstract][Full Text] [Related]
3. Tumor-suppression functions of merlin are independent of its role as an organizer of the actin cytoskeleton in Schwann cells.
Lallemand D; Saint-Amaux AL; Giovannini M
J Cell Sci; 2009 Nov; 122(Pt 22):4141-9. PubMed ID: 19910496
[TBL] [Abstract][Full Text] [Related]
4. Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin.
Meng JJ; Lowrie DJ; Sun H; Dorsey E; Pelton PD; Bashour AM; Groden J; Ratner N; Ip W
J Neurosci Res; 2000 Nov; 62(4):491-502. PubMed ID: 11070492
[TBL] [Abstract][Full Text] [Related]
5. Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function.
Surace EI; Haipek CA; Gutmann DH
Oncogene; 2004 Jan; 23(2):580-7. PubMed ID: 14724586
[TBL] [Abstract][Full Text] [Related]
6. Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin.
Grönholm M; Sainio M; Zhao F; Heiska L; Vaheri A; Carpén O
J Cell Sci; 1999 Mar; 112 ( Pt 6)():895-904. PubMed ID: 10036239
[TBL] [Abstract][Full Text] [Related]
7. Multistep phosphorylation by oncogenic kinases enhances the degradation of the NF2 tumor suppressor merlin.
Laulajainen M; Muranen T; Nyman TA; Carpén O; Grönholm M
Neoplasia; 2011 Jul; 13(7):643-52. PubMed ID: 21750658
[TBL] [Abstract][Full Text] [Related]
8. Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene.
Golovnina K; Blinov A; Akhmametyeva EM; Omelyanchuk LV; Chang LS
BMC Evol Biol; 2005 Dec; 5():69. PubMed ID: 16324214
[TBL] [Abstract][Full Text] [Related]
9. The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells.
Bashour AM; Meng JJ; Ip W; MacCollin M; Ratner N
Mol Cell Biol; 2002 Feb; 22(4):1150-7. PubMed ID: 11809806
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the hyaluronan-CD44 interaction by merlin contributes to the tumor-suppressor activity of merlin.
Bai Y; Liu YJ; Wang H; Xu Y; Stamenkovic I; Yu Q
Oncogene; 2007 Feb; 26(6):836-50. PubMed ID: 16953231
[TBL] [Abstract][Full Text] [Related]
11. Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton.
Sainio M; Zhao F; Heiska L; Turunen O; den Bakker M; Zwarthoff E; Lutchman M; Rouleau GA; Jääskeläinen J; Vaheri A; Carpén O
J Cell Sci; 1997 Sep; 110 ( Pt 18)():2249-60. PubMed ID: 9378774
[TBL] [Abstract][Full Text] [Related]
12. The tumor suppressor merlin interacts with microtubules and modulates Schwann cell microtubule cytoskeleton.
Muranen T; Grönholm M; Lampin A; Lallemand D; Zhao F; Giovannini M; Carpén O
Hum Mol Genet; 2007 Jul; 16(14):1742-51. PubMed ID: 17566081
[TBL] [Abstract][Full Text] [Related]
13. Binding of the merlin-I product of the neurofibromatosis type 2 tumour suppressor gene to a novel site in beta-fodrin is regulated by association between merlin domains.
Neill GW; Crompton MR
Biochem J; 2001 Sep; 358(Pt 3):727-35. PubMed ID: 11535133
[TBL] [Abstract][Full Text] [Related]
14. Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2.
Wiederhold T; Lee MF; James M; Neujahr R; Smith N; Murthy A; Hartwig J; Gusella JF; Ramesh V
Oncogene; 2004 Nov; 23(54):8815-25. PubMed ID: 15467741
[TBL] [Abstract][Full Text] [Related]
15. Cellular transformation by a FERM domain mutant of the Nf2 tumor suppressor gene.
Johnson KC; Kissil JL; Fry JL; Jacks T
Oncogene; 2002 Sep; 21(39):5990-7. PubMed ID: 12203111
[TBL] [Abstract][Full Text] [Related]
16. The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.
Shaw RJ; Paez JG; Curto M; Yaktine A; Pruitt WM; Saotome I; O'Bryan JP; Gupta V; Ratner N; Der CJ; Jacks T; McClatchey AI
Dev Cell; 2001 Jul; 1(1):63-72. PubMed ID: 11703924
[TBL] [Abstract][Full Text] [Related]
17. Serine 518 phosphorylation modulates merlin intramolecular association and binding to critical effectors important for NF2 growth suppression.
Rong R; Surace EI; Haipek CA; Gutmann DH; Ye K
Oncogene; 2004 Nov; 23(52):8447-54. PubMed ID: 15378014
[TBL] [Abstract][Full Text] [Related]
18. NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.
James MF; Han S; Polizzano C; Plotkin SR; Manning BD; Stemmer-Rachamimov AO; Gusella JF; Ramesh V
Mol Cell Biol; 2009 Aug; 29(15):4250-61. PubMed ID: 19451225
[TBL] [Abstract][Full Text] [Related]
19. Akt phosphorylation regulates the tumour-suppressor merlin through ubiquitination and degradation.
Tang X; Jang SW; Wang X; Liu Z; Bahr SM; Sun SY; Brat D; Gutmann DH; Ye K
Nat Cell Biol; 2007 Oct; 9(10):1199-207. PubMed ID: 17891137
[TBL] [Abstract][Full Text] [Related]
20. Localization and functional domains of the neurofibromatosis type II tumor suppressor, merlin.
Shaw RJ; McClatchey AI; Jacks T
Cell Growth Differ; 1998 Apr; 9(4):287-96. PubMed ID: 9563848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]